scholarly journals A Multi-Center Phase II Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody Amatuximab in Combination with Chemotherapy for Frontline Therapy of Malignant Pleural Mesothelioma: Updated Clinical Outcomes and Correlative Studies

2012 ◽  
Vol 23 ◽  
pp. ix493
Author(s):  
M. Reck ◽  
R. Hassan ◽  
T. Jahan ◽  
H.L. Kindler ◽  
L. Bazhenova ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Monoclonal Antibody ◽  
Clinical Outcomes ◽  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Clinical Trial ◽  
Pleural Mesothelioma ◽  
Frontline Therapy ◽  
Correlative Studies

scholarly journals Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma

2012 ◽  
Vol 7 (9) ◽  
pp. 1466-1470 ◽  
Author(s):  
Dean A. Fennell ◽  
Cliona McDowell ◽  
Sara Busacca ◽  
Glen Webb ◽  
Brian Moulton ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Clinical Trial ◽  
Pleural Mesothelioma ◽  
Line Treatment ◽  
Second Line

Taxotere in malignant pleural mesothelioma. A phase II clinical trial

Lung Cancer ◽  
2000 ◽  
Vol 29 (1) ◽  
pp. 19 ◽  
Author(s):  
D.A Vorobiof ◽  
M.R Chasen ◽  
R Abratt ◽  
B Rapoport ◽  
N Cronje ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Clinical Trial ◽  
Pleural Mesothelioma

Treatment of intraoral ranulas with micromarsupialization: Clinical outcomes and safety from a phase II clinical trial

Head & Neck ◽  
2014 ◽  
Vol 37 (2) ◽  
pp. 197-201 ◽  
Author(s):  
Seung Hoon Woo ◽  
Jun Hyuk Chi ◽  
Bo Hae Kim ◽  
Seong Keun Kwon
Keyword(s):  
Clinical Trial ◽  
Clinical Outcomes ◽  
Phase Ii ◽  
Phase Ii Clinical Trial

scholarly journals Phase ii clinical trial, testing the efficacy of a humanized monoclonal antibody against the Lewis-Y antigen (Le y)

Mastology ◽  
2018 ◽  
Vol 28 (s1) ◽  
pp. 11-11
Author(s):  
Laura Testa ◽  
◽  
Ruffo Freitas- Junior ◽  
Sergio V Serrano ◽  
Roberto J Arai ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Monoclonal Antibody ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Lewis Y Antigen ◽  
Humanized Monoclonal Antibody ◽  
Trial Testing ◽  
Lewis Y

scholarly journals Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma

2014 ◽  
Vol 20 (23) ◽  
pp. 5927-5936 ◽  
Author(s):  
Raffit Hassan ◽  
Hedy L. Kindler ◽  
Thierry Jahan ◽  
Lyudmila Bazhenova ◽  
Martin Reck ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Pleural Mesothelioma
Sign in / Sign up

Export Citation Format

Share Document